Cover Image
市場調查報告書

EpiCast Report:骨關節炎 (OA) - 至2024年的流行病學預測

EpiCast Report: Osteoarthritis - Epidemiology Forecast to 2024

出版商 GlobalData 商品編碼 345646
出版日期 內容資訊 英文 82 Pages
訂單完成後即時交付
價格
Back to Top
EpiCast Report:骨關節炎 (OA) - 至2024年的流行病學預測 EpiCast Report: Osteoarthritis - Epidemiology Forecast to 2024
出版日期: 2015年11月01日 內容資訊: 英文 82 Pages
簡介

在全球主要7個國家(美國、法國、德國、義大利、西班牙、英國、日本),手的骨關節炎 (OA) 確診的患者數,從2014年的150,635,612人預測今後10年達到175,213,683人,1.63%的年度成長率。膝的骨關節炎 (OA) 確診的患者數,從2014年的110,840,501人預測今後10年達到127,929,359人,1.54%的年度成長率。髖關節的骨關節炎 (OA) 確診的患者數,從2014年的61,150,916人預測今後10年達到69,699,696人,1.4%的年度成長率。

本報告提供全球主要7個國家的骨關節炎 (OA) 調查分析、疾病的背景、危險因素和共生病症、全球趨勢、流行病學預測等相關的系統性資訊。

第1章 目錄

第2章 簡介

第3章 流行病學

  • 疾病的背景
  • 危險因素和共生病症
  • 全球趨勢
    • 主要7個國家
  • 預測手法
    • 利用之資訊來源
    • 未利用之資訊來源
    • 預測的前提條件與手法
  • 骨關節炎 (OA) 的流行病學預測
    • 總患者數
    • 髖關節OA的總患者數:性別
    • 確診的患者數
    • 基於膝OA的重病度 (KL等級)
  • 議論
    • 流行病學預測相關考察
    • 分析的限制
    • 分析的優勢

第4章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHCER101-15

OA is a degenerative disease of the entire joint, which involves the cartilage, joint lining, ligaments, and underlying bone. OA is the most common form of joint disease. The most affected joints are the knee, hip, hand, and spine. The disease's onset is gradual and typically seen in middle-aged to elderly people. OA is characterized by pain, stiffness, swelling, crepitus, and limited movement of the affected joint. OA will be the fourth leading cause of disability by the year 2020.

GlobalData epidemiologists forecast an increase in the total prevalent cases of hand OA in the 7MM from 151,439,533150,635,612 total prevalent cases in 2014 to 176,143,154175,213,683 total prevalent cases in 2024 at an AGR of 1.63% during the forecast period. GlobalData epidemiologists forecast that the total prevalent cases of knee OA in the 7MM are expected to increase from 110,840,501 total prevalent cases in 2014 to 127,929,359 total prevalent cases in 2024 at an AGR of 1.54% during the forecast period. GlobalData epidemiologists forecast that the total prevalent cases of hip OA in the 7MM are expected to increase from 61,150,916 total prevalent cases in 2014 to 69,699,696 total prevalent cases in 2024 at an AGR of 1.4% during the forecast period. The diagnosed prevalent cases of hand OA in the 7MM are expected to increase from 61,045,59060,125,229 diagnosed prevalent cases in 2014 to 70,996,37570,072,690 diagnosed prevalent cases in 2024 at an AGR of 1.635% during the forecast period. The diagnosed prevalent cases of knee OA in the 7MM are expected to increase from 37,845,305 diagnosed prevalent cases in 2014 to 43,877,213 diagnosed prevalent cases in 2024 at an AGR of 1.59% during the forecast period. The diagnosed prevalent cases of hip OA in the 7MM are expected to increase from 15,116,094 diagnosed prevalent cases in 2014 to 17,276,030 diagnosed prevalent cases in 2024 at an AGR of 1.43% during the forecast period.

Scope

  • The Osteoarthritis (OA) EpiCast Report provides an overview of the risk factors, comorbidities, and the global and historical trends for hand OA, knee OA, and hip OA in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). The report also includes a 10-year epidemiological forecast for the total prevalent cases and diagnosed prevalent cases of hand OA, knee OA, and hip OA segmented by age and sex in these markets.
  • The OA epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The OA EpiCast report will allow you to -

  • Develop business strategies by understanding the trends shaping and driving the global OA market.
  • Quantify patient populations in the global OA market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for OA therapeutics in each of the markets covered.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports

3. Epidemiology

  • 3.1. Disease Background
  • 3.2. Risk Factors and Comorbidities
  • 3.3. Global Trends
    • 3.3.1. Total Prevalence of OA - 7MM
    • 3.3.2. Diagnosed Prevalence of OA - 7MM
  • 3.4. Forecast Methodology
    • 3.4.1. Sources Used
    • 3.4.2. Sources Not Used
    • 3.4.3. Forecast Assumptions and Methods
  • 3.5. Epidemiological Forecast for OA (2014-2024)
    • 3.5.1. Total Prevalent Cases
    • 3.5.2. Diagnosed Prevalent Cases
    • 3.5.3. Severity of Knee OA based on KL Grades
  • 3.6. Discussion
    • 3.6.1. Epidemiological Forecast Insight
    • 3.6.2. Limitations of the Analysis
    • 3.6.3. Strengths of the Analysis

4. Appendix

  • 4.1. Bibliography
  • 4.2. About the Authors
    • 4.2.1. Epidemiologists
    • 4.2.2. Reviewers
    • 4.2.3. Global Director of Therapy Analysis and Epidemiology
    • 4.2.4. Global Head of Healthcare
  • 4.3. About GlobalData
  • 4.4. About EpiCast
  • 4.5. Disclaimer

List of Tables

  • Table 1: Hand, Knee, and Hip OA Severity Scoring System Using the Kellgren Lawrence Scale
  • Table 2: Risk Factors and Comorbidities for OA
  • Table 3: Global Estimates for the Diagnosed Prevalence of OA
  • Table 4: 7MM, Sources of Epidemiological Data Used for the Forecast for Hand OA Total Prevalent Cases
  • Table 5: 7MM, Sources of Epidemiological Data Used for the Forecast of Knee OA Total Prevalent Cases
  • Table 6: 7MM, Sources of Epidemiological Data Used for the Forecast of Hip OA Total Prevalent Cases
  • Table 7: 7MM, Sources of Epidemiological Data Used for the Forecast of Hand OA Diagnosed Prevalent Cases
  • Table 8: 7MM, Sources of Epidemiological Data Used for the Forecast of Knee OA Diagnosed Prevalent Cases
  • Table 9: 7MM, Sources of Epidemiological Data Used for the Forecast of Hip OA Diagnosed Prevalent Cases
  • Table 10: 7MM, Sources of Epidemiological Data Used for the Severity* of Knee OA based on KL Grade
  • Table 11: 7MM, Total Prevalent Cases of Hand OA, Both Sexes, Ages ≥20 Years, N, 2014-2024
  • Table 12: 7MM, Age-Specific Total Prevalent Cases of Hand OA, Both Sexes, N (Row %), 2014
  • Table 13: 7MM, Sex-Specific Total Prevalent Cases of Hand OA, Ages ≥20 Years, N (Row %), 2014
  • Table 14: 7MM, Total Prevalent Cases of Knee OA, Both Sexes, Ages ≥20 Years, N, 2014-2024
  • Table 15: 7MM, Age-Specific Total Prevalent Cases of Knee OA, Both Sexes, N (Row %), 2014
  • Table 16: 7MM, Sex-Specific Total Prevalent Cases of Knee OA, Ages ≥20 Years, N (Row %), 2014
  • Table 17: 7MM, Total Prevalent Cases of Hip OA, Both Sexes, Ages ≥20 Years, N, 2014-2024
  • Table 18: 7MM, Age-Specific Total Prevalent Cases of Hip OA, Both Sexes, N (Row %), 2014
  • Table 19: 7MM, Sex-Specific Total Prevalent Cases of Hip OA, Ages ≥20 Years, N (Row %), 2014
  • Table 20: 7MM, Diagnosed Prevalent Cases of Hand OA, Both Sexes, Ages ≥20 Years, N, 2014-2024
  • Table 21: 7MM, Age-Specific Diagnosed Prevalent Cases of Hand OA, Both Sexes, N (Row %), 2014
  • Table 22: 7MM, Sex-Specific Diagnosed Prevalent Cases of Hand OA, Ages ≥20 Years, N (Row %), 2014
  • Table 23: 7MM, Diagnosed Prevalent Cases of Knee OA, Both Sexes, Ages ≥20 Years, N, 2014-2024
  • Table 24: 7MM, Age-Specific Diagnosed Prevalent Cases of Knee OA, Both Sexes, N (Row %), 2014
  • Table 25: 7MM, Sex-Specific Diagnosed Prevalent Cases of Knee OA, Ages ≥20 Years, N (Row %), 2014
  • Table 26: 7MM, Diagnosed Prevalent Cases of Hip OA, Both Sexes, Ages ≥20 Years, N, 2014-2024
  • Table 27: 7MM, Age-Specific Diagnosed Prevalent Cases of Hip OA, Both Sexes, N (Row %), 2014
  • Table 28: 7MM, Sex-Specific Diagnosed Prevalent Cases of Hip OA, Ages ≥20 Years, N (Row %), 2014
  • Table 29: 7MM, Total and Diagnosed Prevalent Cases of Knee OA by Severity based on KL Grades, Both Sexes, Ages ≥20 Years, N, 2014

List of Figures

  • Figure 1: 7MM, Total Prevalent Cases of Hand OA, Both Sexes, Ages ≥20 Years, N, 2014-2024
  • Figure 2: 7MM, Total Prevalent Cases of Hand OA by Age Group, Both Sexes, N, 2014
  • Figure 3: 7MM, Total Prevalent Cases of Hand OA by Sex, Ages ≥20 Years, N, 2014
  • Figure 4: 7MM, Total Prevalent Cases of Knee OA, Both Sexes, Ages ≥20 Years, N, 2014-2024
  • Figure 5: 7MM, Total Prevalent Cases of Knee OA by Age Group, Both Sexes, N, 2014
  • Figure 6: 7MM, Total Prevalent Cases of Knee OA by Sex, Ages ≥20 Years, N, 2014
  • Figure 7: 7MM, Total Prevalent Cases of Hip OA, Both Sexes, Ages ≥20 Years, N, 2014-2024
  • Figure 8: 7MM, Total Prevalent Cases of Hip OA by Age Group, Both Sexes, N, 2014
  • Figure 9: 7MM, Total Prevalent Cases of Hip OA by Sex, Ages ≥20 Years, N, 2014
  • Figure 10: 7MM, Diagnosed Prevalent Cases of Hand OA, Both Sexes, Ages ≥20 Years, N, 2014-2024
  • Figure 11: 7MM, Diagnosed Prevalent Cases of Hand OA by Age Group, Both Sexes, N, 2014
  • Figure 12: 7MM, Diagnosed Prevalent Cases of Hand OA by Sex, Ages ≥20 Years, N, 2014
  • Figure 13: 7MM, Diagnosed Prevalent Cases of Knee OA, Both Sexes, Ages ≥20 Years, N, 2014-2024
  • Figure 14: 7MM, Diagnosed Prevalent Cases of Knee OA by Age Group, Both Sexes, N, 2014
  • Figure 15: 7MM, Diagnosed Prevalent Cases of Knee OA by Sex, Ages ≥20 Years, N, 2014
  • Figure 16: 7MM, Diagnosed Prevalent Cases of Hip OA, Both Sexes, Ages ≥20 Years, N, 2014-2024
  • Figure 17: 7MM, Diagnosed Prevalent Cases of Hip OA by Age Group, Both Sexes, N, 2014
  • Figure 18: 7MM, Diagnosed Prevalent Cases of Hip OA by Sex, Ages ≥20 Years, N, 2014
Back to Top